3 active not recruiting, 2 recruiting, 2 unknown, 1 terminated. 3 Not applicable, 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 2, Terminated 1 |
| Phase 1 | 3 | Active not recruiting 2, Unknown 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow LUNGevity Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors Lung Cancer Screening Education, Semi-Structured Interview, Standard of Care Lung Cancer Screening Program - Head and Neck Cancer | Not applicable | Recruiting | University of Miami | 44 | 2024-04-11 | 2026-04-28 |
| Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer Hypofractionated accelerated radiation therapy - Lung Cancer | Not applicable | Recruiting | Stanford University | 45 | 2023-10-25 | 2026-10-07 |
| An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer Alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside, Computed Tomography, Laboratory Biomarker Analysis - Lung Adenocarcinoma | Phase 1 / Phase 2 | Active not recruiting | Jonsson Comprehensive Cancer Center | 60 | 2023-01-19 | 2026-11-09 |
| Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer Liver SBRT, Pembrolizumab - Liver Metastases, Non-small Cell Lung Cancer | Phase 1 | Unknown | VA Ann Arbor Healthcare System | 12 | 2022-06-17 | 2022-08-01 |
| A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle Patient Navigation, Questionnaire Administration, Smoking Cessation Intervention - Lung Carcinoma | Not applicable | Terminated | Fred Hutchinson Cancer Center | 53 | 2022-06-06 | 2024-12-02 |
| Immune and Genomic Markers in ALK+ NSCLC Anaplastic Lymphoma Kinase Gene Translocation, Non-Small Cell Lung Cancer | Active not recruiting | Massachusetts General Hospital | 100 | 2021-12-01 | 2026-03-30 | |
| Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting There are no interventions in this study. All participants complete online surveys. - Lung Cancer Patients, Caregivers | Unknown | LUNGevity Foundation | 1300 | 2020-08-15 | 2023-04-28 | |
| CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer Autologous Dendritic Cell-Adenovirus CCL21 Vaccine, Pembrolizumab - Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 24 | 2019-07-08 | 2025-01-14 |
Carcinoma, Non-Small-Cell Lung (4) · Lung Neoplasms (4) · Adenocarcinoma of Lung (1) · Head and Neck Neoplasms (1) · Small Cell Lung Carcinoma (1) · Tobacco Use (1)
pembrolizumab (2) · Carbon Monoxide (1) · Magnetic Resonance Spectroscopy (1) · Patient Navigation (1) · Smoking Devices (1) · methyl-4-fluoro-4-deoxyglucose (1)
United States (8)
Claudio Scafoglio, MD, PhD (1) · Coral Olazagasti, MD (1) · Edward B Garon (1) · Jessica J Lin, MD (1) · Joseph A Jaoude, MD (1) · Matthew Triplette (1) · Michael Green, MD (1) · Upal Basu Roy, PhD, MPH (1)
K08CA245249 (1), K12CA226330 (1)